Table 1.
Characteristic or Marker | Patients With CCUS (n = 80) |
---|---|
Age, median (range), y | 72 (19-92) |
Sex, No. (%) | |
F | 21 (26) |
M | 59 (74) |
Splenomegaly, No. (%) | |
No | 66 (83) |
Yes | 14 (18) |
Prior chemotherapy or RT, No. (%) | |
No | 70 (88) |
Yes | 10 (13) |
ANC, median (range), ×109/L | 2.0 (0-40) |
ALC, median (range), ×109/L | 1.26 (0.16-40) |
WBC, median (range), ×109/L | 4.0 (0.3-23) |
Hemoglobin, median (range), g/dL | 10.5 (6.8-14.9) |
Platelet count, median (range), ×109/L | 126 (7-595) |
High LDH (>222 U/L), No. (%) | |
No | 23 (50) |
Yes | 23 (50) |
High ferritin (>336 µg/L), No. (%) | |
No | 31 (39) |
Yes | 21 (26) |
Loss of Y chromosome, No. (%) | |
No | 76 (95) |
Yes | 4 (5) |
del(20)(q11.q13.1), No. (%) | |
No | 77 (96) |
Yes | 3 (4) |
Loss of X chromosome, No. (%) | |
No | 78 (97) |
Yes | 2 (3) |
ALC, absolute lymphocyte count; ANC, absolute neutrophil count; CCUS, clonal cytopenia of undetermined significance; LDH, lactate dehydrogenase; RT, radiation therapy.